Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uremia”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Not applicableLooking for participantsNCT03629977
What this trial is testing

Timing of Renal Replacement Therapy in the Critically Ill Patients

Who this might be right for
Acute Kidney InjuryUremiaFluid Overload+2 more
Karolinska University Hospital 50,000
Not applicableUnknownNCT03605511
What this trial is testing

TTP and aHUS in Complicated Pregnancies

Who this might be right for
Thrombotic Thrombocytopenic PurpuraAtypical Hemolytic Uremic SyndromePre-Eclampsia+5 more
University College, London 150
Testing effectiveness (Phase 2)Study completedNCT01194973
What this trial is testing

An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 44
Not applicableLooking for participantsNCT07522008
What this trial is testing

ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms

Who this might be right for
Chronic Kidney Disease 5DUremia; Chronic
Azienda Ospedaliera Brotzu 120
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Not applicableUnknownNCT06098378
What this trial is testing

Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab

Who this might be right for
Thrombotic Microangiopathies
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT07086430
What this trial is testing

Independent Effects of Visceral Adipose Volume and Density on Patient Survival in Peritoneal Dialysis

Who this might be right for
UremiaEnd Stage Renal Disease on Dialysis
RenJi Hospital 358
Testing effectiveness (Phase 2)UnknownNCT00531089
What this trial is testing

Rituximab in Patients With Relapsed or Refractory TTP-HUS

Who this might be right for
Thrombotic Thrombocytopenic PurpuraHemolytic Uremic Syndrome
Hamilton Health Sciences Corporation 60
Testing effectiveness (Phase 2)Study completedNCT01193348
What this trial is testing

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 22
Post-approval studies (Phase 4)Study completedNCT00388648
What this trial is testing

Very Low Protein Diet or Dialysis in Uremic Elderly?

Who this might be right for
UremiaElderly (Aged >70)Dialysis+2 more
Università degli Studi di Brescia 160
Not applicableLooking for participantsNCT01522183
What this trial is testing

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 3,000
Not applicableStudy completedNCT02902705
What this trial is testing

Adipose Tissue & Uremia

Who this might be right for
Chronic Kidney Disease - Stage V
Hospices Civils de Lyon 23
Testing effectiveness (Phase 2)WithdrawnNCT03999840
What this trial is testing

Eculizumab to Cemdisiran Switch in aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Mario Negri Institute for Pharmacological Research
Testing effectiveness (Phase 2)WithdrawnNCT00172367
What this trial is testing

Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional Cell
National Taiwan University Hospital 80
Not applicableLooking for participantsNCT05219110
What this trial is testing

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Who this might be right for
Shiga Toxin-Producing Escherichia Coli (E. Coli) InfectionHemolytic-Uremic Syndrome
University of Calgary 1,040
Testing effectiveness (Phase 2)Study completedNCT00844545
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 16
Not applicableUnknownNCT03580941
What this trial is testing

Usefulness of a Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in Pregnancy

Who this might be right for
Hemolytic-Uremic Syndrome
Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia 75
Large-scale testing (Phase 3)Ended earlyNCT00004465
What this trial is testing

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Who this might be right for
Hemolytic Uremic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 145
Not applicableStudy completedNCT00786708
What this trial is testing

Sensitivity and Specificity of NGAL in an Emergency Room Population

Who this might be right for
AzotemiaRenal Insufficiency, ChronicRenal Failure, Acute+1 more
Columbia University 2,304
Testing effectiveness (Phase 2)Study completedNCT01757431
What this trial is testing

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome (aHUS)
Alexion Pharmaceuticals, Inc. 2
Next Page